ArticleJournal of translational internal medicine2026
Unraveling the enigma: Post-translational modifications in psychiatric disorders and their regulatory mechanisms.
Article in Journal of translational internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder, are a group of categorical syndromes characterized by significant impairment of an individual's cognition, emotional regulation, or abnormal behavior, causing severe distress and impairment in social functioning. Post-translational modifications (PTMs), such as phosphorylation, ubiquitination, and acetylation, are fundamental regulatory mechanisms in the brain, influencing diverse processes ranging from neuronal differentiation, synaptic plasticity, and neurotransmission, shaping the intricate cellular dynamics of the central nervous system. Understanding PTMs regulation in psychiatric disorders unveils their crucial functions in shaping neural networks, impacting learning and memory through mechanisms like long-term potentiation and depression. Additionally, disruptions in PTMs patterns have been associated with psychiatric disorders, suggesting their potential as therapeutic targets. Considering the critical role of PTMs in various cellular processes and signaling pathways, they could be a breakthrough in understanding psychiatric disorders. A holistic exploration of the PTMs landscape holds transformative promise for comprehending and managing a spectrum of psychiatric disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.